Conventional ultrasound detected only two islet cell tumours, and showed diffuse pancreatic abnormality in the patient with multiple endocrine adenopathy type 1. Computed tomography identified three insulinomas and showed the 20 mm glucagonoma.
The site of five lesions was suspected on conventional imaging before endoscopic ultrasound. No adverse effects were noted in any of the patients after endoscopic ultrasound.
Discussion
Most patients in this series were referred for endoscopic ultrasound because of the failure of other imaging modalities, which is reflected in the very low sensitivities of computed tomography (25%) and ultrasound (18%) (Table III) compared with other series.5-8 Most of the lesions were less than 19 mm and five were less than 9 mm (Fig 1) .
Some investigators advocate computed tomography and selective angiography for preoperative localisation of pancreatic endocrine tumours,6 but angiography is more invasive than endoscopic ultrasound and has a greater risk of adverse events. In this series six of the insulinoma patients were investigated by angiography and computed tomography but none of the lesions was correctly located, and one of the lesions (case 11) was localised to the head rather than the uncinate lobe and could not be found at subsequent laparotomy performed before endoscopic ultrasound. Endoscopic ultrasound is safe and noninvasive compared with angiography and venous sampling. The depth of penetration of the ultrasound beam is limited to approximately 6 cm from the transducer, and it produces radial images which require experience to orientate and interpret (Fig 2) . Islet cell tumours generally appear as well circumscribed lesions, hypoechoic compared with the surrounding normal pancreas (Fig 3) .
A proven alternative is peroperative ultrasound scanning after full mobilisation of the pancreas. In recent reports peroperative ultrasound combined with surgical palpation has produced a sensitivity of up to 100%.814 Peroperative scanning may lead the surgeon directly to the lesion but it prolongs surgery and requires a confident preoperative diagnosis which is often difficult to achieve. Localisation by endoscopic ultrasound can greatly reduce the extent of surgical mobilisation required and size of resection. Ultrasonic endoscopes are wider than simple side viewing scopes, with a longer nonflexible tip which can make entry into the duodenum difficult, especially ifthere is scarring (see case 19). However, future ultrasonic endoscopes are likely to be narrower and more flexible. As well as showing pancreatic lesions as small as 6 mm, endoscopic ultrasound also shows the bowel wall with great accuracy, which is important in gastrinoma patients whose lesions may be in the duodenal wall. Endoscopic ultrasound may have a blind spot in the region of the splenic hilum but so may other imaging modalities, as case 2 shows.
We believe that endoscopic ultrasound is a useful adjunct to the investigation and localisation of islet cell tumours, which will replace other more invasive techniques, and we recom- mend it as the next investigation after computed tomography and ultrasound. As pancreatic endocrine tumours may be small and multiple it should be performed in all such patients or small functioning lesions may be missed, particularly 
